Skip to main content

Table 4 The rate of adverse effects by the groups

From: Randomized controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome

Adverse events

Sodium valproate N = 12

( N, %)

Aripiprazole N = 12

(N, %)

Drowsiness

4, 33.3%

0

Nausea

4, 33.3%

0

Xerostomia

0

2, 16.7%

Decreased sleep

0

1, 8.3%

Decreased appetite

0

1, 8.3%

Hypersomnia

0

4, 33.3%

Sensitive

1, 8.3%

0

Tremor

0

1, 8.3%

Back to article page

Annals of General Psychiatry

ISSN: 1744-859X